WhatA platform that aggregates clinical trial results, treatment outcome data, and emerging therapies by specific cancer type and stage, giving patients and families an honest, continuously updated picture of what's actually improving and what trials they could access.
SignalPeople dealing with cancer in their families express deep frustration that despite constant headlines about breakthroughs, they see no meaningful improvement in outcomes for their specific situation — they want a realistic, personalized view of what treatments are actually available and advancing, not hype.
Why NowThe explosion of AI-driven drug discovery, immunotherapy approvals, and nanomedicine research has created an overwhelming volume of oncology data that no patient or oncologist can track — while clinical trial matching remains broken and most patients never learn about trials they qualify for.
Market19M new cancer diagnoses globally per year; patients and caregivers already pay for second opinions, concierge oncology ($5-25K), and trial matching services. Key gap: existing resources like ClinicalTrials.gov are unusable by normal humans, and trial matching startups focus on enrollment not patient empowerment.
MoatStructured outcome data aggregated across trials and real-world evidence becomes a proprietary dataset; network effects as oncologists contribute and validate information; high trust and switching costs once a patient relies on the platform during treatment.
New iron nanomaterial wipes out cancer cells without harming healthy tissueView discussion ↗ · Article ↗ · 322 pts · March 1, 2026
Annotated Source Code Explainer for AI CodebasesC5/10An automated tool that generates beautiful, line-by-line annotated documentation for AI/ML codebases in the style of the classic annotated Backbone.js source.
Consumer-Grade Local LLM Training ToolkitC6/10A turnkey software package that lets anyone train small language models on their own data using consumer laptops with clear time and resource estimates upfront.
AI Vendor Government Risk Intelligence PlatformP6/10A real-time monitoring and risk assessment platform that tracks government actions, designations, and policy changes affecting AI vendors and their enterprise customers.
AI Government Relations and Policy TrackerC6/10A structured, continuously updated timeline and alerting tool that tracks interactions between AI companies and governments — contracts, designations, lobbying, executive orders, and personnel moves.
Multi-Cloud AI API Abstraction and Failover LayerC7/10An API gateway that abstracts across multiple LLM providers with automatic failover, so enterprises aren't locked into a single AI vendor that could be politically disrupted overnight.